These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 6196689

  • 1. [Asymptomatic electrocardiographic abnormalities during antiblastic chemotherapy].
    Bottoni P, Bobba L, Ranieri MG, Croce M, Zaietta P, Provera F.
    Minerva Med; 1983 Oct 06; 74(38):2211-8. PubMed ID: 6196689
    [Abstract] [Full Text] [Related]

  • 2. Alternating cyclical hormonal-cytotoxic combination chemotherapy in postmenopausal patients with breast cancer. An EORTC trial.
    Heuson JC, Sylvester R, Engelsman E.
    Eur J Cancer (1965); 1980 Oct 06; Suppl 1():113-7. PubMed ID: 7032920
    [No Abstract] [Full Text] [Related]

  • 3. [Comparison of several different methods of antiblastic therapy in advanced carcinomas of the digestive system].
    Missale G, Cocconi G, Pettenati V.
    Cancro; 1974 Oct 06; 27(1):3-14. PubMed ID: 4136011
    [No Abstract] [Full Text] [Related]

  • 4. Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study.
    Rivkin SE, Green SJ, Lew D, Costanzi JJ, Athens JW, Osborne CK, Vaughn CB, Martino S.
    Cancer; 2003 Jan 01; 97(1):21-9. PubMed ID: 12491501
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Hormono-chemotherapy versus hormonotherapy followed by chemotherapy in the treatment of disseminated breast cancer.
    Cavalli F, Alberto P, Jungi F, Brunner K, Martz G.
    Eur J Cancer (1965); 1980 Jan 01; Suppl 1():125-9. PubMed ID: 7032922
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Prospective randomized trial on the efficacy of adjuvant endocrine therapy for ER-positive breast cancer patients after radical mastectomy].
    Jiang Z, Song S, Liu X.
    Zhonghua Zhong Liu Za Zhi; 2001 Sep 01; 23(5):420-2. PubMed ID: 11810777
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Tamoxifen versus control after adjuvant, risk-adapted chemotherapy in postmenopausal, receptor-negative patients with breast cancer: a randomized trial (GABG-IV D-93)--the German Adjuvant Breast Cancer Group.
    Kaufmann M, Graf E, Jonat W, Eiermann W, Geberth M, Albert US, Gademann G, Conrad B, Stahl K, von Minckwitz G, Schumacher M, German Adjuvant Breast Cancer Group.
    J Clin Oncol; 2005 Nov 01; 23(31):7842-8. PubMed ID: 16258087
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Encouraging results with cytostatic therapy in metastasizing breast cancer (author's transl)].
    Michlmayr G, Kratzer H, Denz H, Huber H.
    Wien Klin Wochenschr; 1981 Mar 20; 93(6):205-7. PubMed ID: 7281697
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.